Medicinova Inc (MNOV)
NASDAQ: MNOVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.62 +0.62%
MNOV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $79.25M
- EPS (TTM)
- -$0.21
- Dividend yield
- None
- 52-week range
- 1.17 – 3.90
- Day range
- 1.60 – 1.65
- Volume / Avg
- 77.97K / 325.17K
- Beta
- —
- Shares outstanding
- 49.22M
- Next earnings
- Nov 12, 2026
52-week range
MNOV stock today
Medicinova (MNOV) closed at $1.61 on Oct 7, down 2.42% (-$0.04), versus the S&P 500's 0.22% decline. Trading was light, with 77.97K shares changing hands, about 24% of the average daily volume. At this level, MNOV sits near the bottom of its 52-week range of $1.17 to $3.90: 58.7% below the high, set on Sep 17, 2026 and 37.6% above the low.
MNOV is up 22.9% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 28.8%. Medicinova has posted a net loss over the last twelve months (EPS of -$0.21), so its P/E ratio is not meaningful. Medicinova's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Medicinova
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- La Jolla, CA
Earnings
Earnings history- Next report
- Nov 12, 2026
Medicinova peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NTHINeOnc Technologies Holdings Inc. | 2.71 | -9.36% | $78.06M | vs MNOV |
| ACRVAcrivon Therapeutics Inc. | 1.88 | +1.08% | $80.56M | vs MNOV |
| PDSBPDS Biotechnology Corporation | 1.07 | +1.91% | $77.19M | vs MNOV |
| INCRIntercure Ltd. | 5.13 | -3.57% | $76.97M | vs MNOV |
| RFLRafael Holdings Inc. Class B | 1.48 | -0.67% | $76.96M | vs MNOV |
| PMNProMIS Neurosciences Inc. | 9.12 | -0.98% | $81.79M | vs MNOV |
| TELOTelomir Pharmaceuticals Inc. | 1.12 | -6.67% | $82.45M | vs MNOV |
| ONCYOncolytics Biotech Inc. | 0.5958 | -0.37% | $75.97M | vs MNOV |
Indexes, lists and sector
Medicinova stock FAQ
What is Medicinova's stock price today?
MNOV last traded at $1.61 as of Oct 7, 4:00 PM EDT, down 2.42% on the day. Prices are delayed at least 15 minutes.
When is Medicinova's next earnings date?
Medicinova is expected to report earnings on Thursday, November 12, 2026.
What is the MNOV 52-week high?
The 52-week high for MNOV is $3.90 and the 52-week low is $1.17. The stock is currently 58.7% below its high.